Cite
Is familial papillary thyroid carcinoma different from sporadic form in terms of clinicopathological features and outcome?
MLA
Berna Ogmen, et al. “Is Familial Papillary Thyroid Carcinoma Different from Sporadic Form in Terms of Clinicopathological Features and Outcome?” B-ENT, vol. 16, Apr. 2021, pp. 222–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........efbb801ee9971f263d8b363bc22f16f4&authtype=sso&custid=ns315887.
APA
Berna Ogmen, Cevdet Aydin, Fatma Dilek Dellal, Aydan Kilicarslan, Mehmet Kılıç, Didem Ozdemir, Bekir Cakir, & Reyhan Ersoy. (2021). Is familial papillary thyroid carcinoma different from sporadic form in terms of clinicopathological features and outcome? B-ENT, 16, 222–228.
Chicago
Berna Ogmen, Cevdet Aydin, Fatma Dilek Dellal, Aydan Kilicarslan, Mehmet Kılıç, Didem Ozdemir, Bekir Cakir, and Reyhan Ersoy. 2021. “Is Familial Papillary Thyroid Carcinoma Different from Sporadic Form in Terms of Clinicopathological Features and Outcome?” B-ENT 16 (April): 222–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........efbb801ee9971f263d8b363bc22f16f4&authtype=sso&custid=ns315887.